Matches in Nanopublications for { ?s ?p "[N-acetyltransferase 2 slow acetylator genotype associated with adverse effects of sulphasalazine in the treatment of inflammatory bowel disease.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 8 of
8
with 100 items per page.
- assertion description "[N-acetyltransferase 2 slow acetylator genotype associated with adverse effects of sulphasalazine in the treatment of inflammatory bowel disease.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP23786.RAK68gLCFfpuJXc06ygMac1amSrDOQ8d6jkyGvh4ffQXk130_assertion description "[N-acetyltransferase 2 slow acetylator genotype associated with adverse effects of sulphasalazine in the treatment of inflammatory bowel disease.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP23786.RAK68gLCFfpuJXc06ygMac1amSrDOQ8d6jkyGvh4ffQXk130_provenance.
- NP23431.RA3WHJZhfz53dYucR2BB7YCmKFvg3AMyyP81dzEUEr5z4130_assertion description "[N-acetyltransferase 2 slow acetylator genotype associated with adverse effects of sulphasalazine in the treatment of inflammatory bowel disease.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP23431.RA3WHJZhfz53dYucR2BB7YCmKFvg3AMyyP81dzEUEr5z4130_provenance.
- NP600412.RAdEx0YXoB9UBNn011A6CPWcEV0X36ar6hPVrXczjRZiE130_assertion description "[N-acetyltransferase 2 slow acetylator genotype associated with adverse effects of sulphasalazine in the treatment of inflammatory bowel disease.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP600412.RAdEx0YXoB9UBNn011A6CPWcEV0X36ar6hPVrXczjRZiE130_provenance.
- NP813522.RAs25uCYzbqp3zVFiaPqtkuhJ4nA4c_LtIhqrE_GOqt8M130_assertion description "[N-acetyltransferase 2 slow acetylator genotype associated with adverse effects of sulphasalazine in the treatment of inflammatory bowel disease.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP813522.RAs25uCYzbqp3zVFiaPqtkuhJ4nA4c_LtIhqrE_GOqt8M130_provenance.
- NP813422.RAzBLRmxTexbbXO0lCO5Eh-yXO-gRuhIc64-xHu3ttJhA130_assertion description "[N-acetyltransferase 2 slow acetylator genotype associated with adverse effects of sulphasalazine in the treatment of inflammatory bowel disease.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP813422.RAzBLRmxTexbbXO0lCO5Eh-yXO-gRuhIc64-xHu3ttJhA130_provenance.
- NP600409.RA5ZD-eDJJPGxvl6yogkFonVVazCcTs9RQezAtONIIz6k130_assertion description "[N-acetyltransferase 2 slow acetylator genotype associated with adverse effects of sulphasalazine in the treatment of inflammatory bowel disease.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP600409.RA5ZD-eDJJPGxvl6yogkFonVVazCcTs9RQezAtONIIz6k130_provenance.
- NP19562.RA5PPtPQ3YVIxvTdKnWK8Jxd2aykK_dWt29XP27SCGmK0130_assertion description "[N-acetyltransferase 2 slow acetylator genotype associated with adverse effects of sulphasalazine in the treatment of inflammatory bowel disease.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP19562.RA5PPtPQ3YVIxvTdKnWK8Jxd2aykK_dWt29XP27SCGmK0130_provenance.